- Report
- February 2024
- 112 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- August 2021
- 116 Pages
Global
From €3200EUR$3,556USD£2,833GBP
- Report
- August 2023
- 103 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- June 2023
- 102 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- June 2021
- 40 Pages
Vietnam
From €2502EUR$2,595USD£2,140GBP
- Report
- June 2021
- 40 Pages
South Korea
From €2502EUR$2,595USD£2,140GBP
- Report
- June 2021
- 40 Pages
Russia
From €2502EUR$2,595USD£2,140GBP
- Report
- June 2021
- 40 Pages
Japan
From €2502EUR$2,595USD£2,140GBP
- Report
- June 2021
- 40 Pages
Ireland
From €2502EUR$2,595USD£2,140GBP
- Report
- June 2021
- 40 Pages
Germany
From €2502EUR$2,595USD£2,140GBP
- Report
- June 2021
- 40 Pages
France
From €2502EUR$2,595USD£2,140GBP
- Report
- June 2021
- 40 Pages
Brazil
From €2502EUR$2,595USD£2,140GBP
- Report
- June 2021
- 80 Pages
Africa
From €3659EUR$3,795USD£3,129GBP
- Report
- December 2023
- 132 Pages
Global
From €916EUR$950USD£783GBP
- Report
- July 2022
- 132 Pages
Global
From €819EUR$850USD£701GBP
- Report
- March 2021
- 64 Pages
Global
€4579EUR$4,750USD£3,917GBP
- Report
- April 2023
- 160 Pages
Global
From €5784EUR$5,999USD£4,946GBP
- Report
- March 2023
- 280 Pages
Global
From €5611EUR$5,820USD£4,799GBP
- Report
- September 2022
- 341 Pages
Global
From €5871EUR$6,090USD£5,021GBP
Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more